Journal of Cardiovascular Disease Research
Comparison of Antihypertensive Efficacy of Amlodipine and Cilnidipine as an add-on drug to Baseline medication in Hypertensive Chronic Kidney Disease patients
Jesmi James, Dhanya Jayakumar, Gomathy Sankaran, Joel Mathew Joseph
JCDR. 2023: 2057-2064
Abstract
The prevalence of chronic kidney disease (CKD) is high in India, with hypertension being a significant contributing factor. The current CKD management guidelines underscore the importance of tight blood pressure control. Cilnidipine, a novel Calcium Channel Blocker (CCB), shows promise due to its unique mechanism of blocking both L and N-type calcium channels, resulting in improved efficacy and fewer adverse effects compared to traditional CCBs like amlodipine
» PDF